Centre inks deal for 30 crore doses of Biological E’s COVID-19 vaccine
Team Udayavani, Jun 3, 2021, 10:06 AM IST
Image Credit: Pixaby
New Delhi: As part of its bid to ramp the vaccination target, the Health Ministry on Thursday announced that it has booked 30 crore doses of Hyderabad-based Biological E’s COVID-19 vaccine.
The vaccine, which is presently undergoing phase 3 clinical trials will be the second made-in-India vaccine to be used in the country after Bharat Biotech’s Covaxin.
An advance payment of Rs.1500 crore will be made by the Ministry to Biological E which will manufacture and stockpile the aforesaid quantity of vaccine doses from August to December 2021.
Earlier opposition parties has targeted the Centre its vaccination policy, as the vaccines were in short supply during the second wave. The government thus paused exports of Covid shots under its “Vaccine Maitri” programme and scrambled to procure more doses to tackle shortage in the country.
The vaccine is likely to be available in the next few months, said the government in a statement.
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
Related Articles More
Congress to discuss candidates for Amethi, Raebareli seats on Saturday
Cache of arms including foreign-made revolvers seized by CBI in Sandeshkhali raids
24 Indian Fishermen Released from Sri Lankan Detention, Repatriated to India
SC verdict on EVM tight slap to Congress-led opposition: PM Modi in Bihar rallies
Board exams twice a year from 2025: MoE asks CBSE to work out logistics, no plan for semesters
MUST WATCH
Latest Additions
Patanjali Foods to evaluate proposal to buy Patanjali Ayurved’s non-food business
Congress to discuss candidates for Amethi, Raebareli seats on Saturday
BJP’s CT Ravi Booked for Promoting Hatred and Enmity Through Social Media Post
Elections held in 14 LS segments in Karnataka, voter turnout nearly 64 per cent till 5 pm
‘PM is scared, may even shed tears on stage’: Rahul Gandhi’s fresh salvo at Modi